Marco Porcu

Marco Porcu, Pharm D, is an experienced Clinical Trial Manager with a focus on oncology, currently leading Phase III trials at Novocure since February 2021. Prior roles include significant positions at Janssen Cilag SpA as Manager of Contracts and Grants and Senior Contract & Grants Analyst, as well as various project management roles at Quintiles and Pierrel Research, where responsibilities ranged from budget management to international clinical study oversight. Early career experience includes CRA positions at Merck, Schering-Plough, and Novartis, highlighting expertise in site management and compliance in clinical studies across multiple therapeutic areas. Marco Porcu holds a Master Degree in Medicinal Chemistry from Università degli Studi di Firenze.